Metriopharm
  • en
  • de
MetrioPharm AG
  • Home
  • About us
    • Management and Board
    • Scientific Advisory Board
    • Senior Advisors
  • Technology
    • MP1000 Platform
    • Mode of Action
    • Scientific Publications
  • Pipeline
    • Overview
    • Clinical Trials
    • Patent Protection
  • Investors
    • IR-News
    • Share Information
    • Financial Reports and Downloads
    • Annual General Meeting
  • Press
    • Press Releases
    • Corporate Calendar
  • Contact
    • Contact form
    • Privacy policy
    • Imprint
  • Blog
  • en
  • de
  1. Home
  2. Investors
  3. Financial Reports and Downloads

Financial Reports and Downloads

MetrioPharm AG Annual Report 2021

MetrioPharm AG Annual Report 2021


Valuation Report (Leverage Experts)

MetrioPharm AG - Valuation (March 2021)


Regulatory Documents

Statutes of MetrioPharm AG (August 2021, German only)


Securities Information Sheet 

Securities Information Sheet in accordance to § 3a Securities Prospectus Act (German only)


Archive

MetrioPharm AG Annual Report 2020

MetrioPharm AG Annual Report 2019

MetrioPharm AG  Annual Report 2018

MetrioPharm AG Annual Report 2017

Investor Relations

Investor Relations News QI 2022 - 2022-Mar-31

Outlook by the Chairman of the Board Rudolf Stäger

» more

Blog

Read our latest blog post: - 2021-May-12

Phase II Clinical Trial in COVID-19

» more

Newsletter Subscription

Subscribe to our press releases with the
MetrioPharm PR newsletter

Investors can subscribe to our quaterly corporate information with the
MetrioPharm IR newsletter

Navigation

  • Home
  • About us
  • Technology
  • Pipeline
  • Investors
  • Press
  • Contact
  • Blog

Social

        

Newsletter

Subscribe to our press releases with the
MetrioPharm PR newsletter

Investors can subscribe to our quaterly corporate information with the
MetrioPharm IR newsletter

Switzerland (HQ)

MetrioPharm AG

Bleicherweg 10
8002 Zurich

Phone: +41 44 562 03 35

Germany (R&D)

MetrioPharm Deutschland GmbH

Am Borsigturm 100
13507 Berlin

Phone: +49 30 3384 395 02

  • © 2022 MetrioPharm AG
  • Imprint
  • Privacy policy
  • Sitemap